In this pilot study, we present first data on therapeutic radiation dosimetry regarding normal organs and tumor lesions for [161Tb]Tb-PSMA-617 compared to [177Lu]Lu-PSMA-617 in 6 patients with mCRPC. Here, FOLH1 is linked to neoplasm.